EdTech Innovations & AI in Education
Superluminal Medicines Secures Oversubscribed $60 Million Series B to Propel AI-Driven GPCR Drug Discovery Into Clinical Trials
Boston, MA — In a milestone transition from a computational discovery engine to a clinical-stage biopharmaceutical powerhouse, Boston-based Superluminal Medicines announced on September 3, 2026,...
